DCF — UNIVERSITY HEALTH TRUMAN MED CENTER
Enterprise Value: $-1.1B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.1B
Enterprise Value
$-350.1M
PV of Cash Flows
$-771.9M
PV of Terminal Value
$-1.2B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $557.1M | $-72.6M | -13.0% | $-96.1M | $-87.4M |
| Year 2 | $573.8M | $-69.0M | -12.0% | $-93.3M | $-77.1M |
| Year 3 | $591.0M | $-65.2M | -11.0% | $-90.2M | $-67.7M |
| Year 4 | $608.7M | $-64.1M | -11.0% | $-89.8M | $-61.4M |
| Year 5 | $627.0M | $-64.4M | -10.0% | $-91.0M | $-56.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.1B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$540.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.13525152908325902
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5